tiprankstipranks
Advertisement
Advertisement

FBLG Stock Latest News

FibroBiologics Faces Material Clinical Trial and Regulatory Risks That Threaten Commercialization Timeline and Long-Term Outlook
Company AnnouncementsFibroBiologics Faces Material Clinical Trial and Regulatory Risks That Threaten Commercialization Timeline and Long-Term Outlook
12h ago
FBLG
FibroBiologics Faces Nasdaq Delisting, Appeals Planned
PremiumCompany Announcements
FibroBiologics Faces Nasdaq Delisting, Appeals Planned
9d ago
8K
FBLG
FibroBiologics files to sell up to 12.53M shares of common stock
PremiumThe Fly
FibroBiologics files to sell up to 12.53M shares of common stock
23d ago
FBLG
FibroBiologics Appoints NASA Scientist Kate Rubins to Board
PremiumCompany Announcements
FibroBiologics Appoints NASA Scientist Kate Rubins to Board
24d ago
8K
FBLG
FibroBiologics appoints Rubins to its Board of Directors
PremiumThe Fly
FibroBiologics appoints Rubins to its Board of Directors
24d ago
FBLG
FibroBiologics completes manufacturing of third batch of CYWC628
PremiumThe FlyFibroBiologics completes manufacturing of third batch of CYWC628
26d ago
FBLG
FibroBiologics Secures New Private Placement Financing
Premium
Company Announcements
FibroBiologics Secures New Private Placement Financing
1M ago
8K
FBLG
FibroBiologics announces $9M private placement priced at-the-market
Premium
The Fly
FibroBiologics announces $9M private placement priced at-the-market
1M ago
FBLG
FibroBiologics Shareholders Approve New 2026 Equity Plan
PremiumCompany Announcements
FibroBiologics Shareholders Approve New 2026 Equity Plan
1M ago
8K
FBLG
FibroBiologics receives notice of allowance for U.S. patent
PremiumThe Fly
FibroBiologics receives notice of allowance for U.S. patent
1M ago
FBLG
FibroBiologics doses first patients in CYWC628 clinical trial
PremiumThe Fly
FibroBiologics doses first patients in CYWC628 clinical trial
2M ago
FBLG
FibroBiologics doses first patients in CYWC628 trial
PremiumThe Fly
FibroBiologics doses first patients in CYWC628 trial
2M ago
FBLG
FibroBiologics presents preclinical data from CYPS317 program
PremiumThe FlyFibroBiologics presents preclinical data from CYPS317 program
2M ago
FBLG
FibroBiologics expands fibroblast-based platform to target Hantavirus
Premium
The Fly
FibroBiologics expands fibroblast-based platform to target Hantavirus
3M ago
FBLG
FibroBiologics Expands At-The-Market Equity Offering Capacity
Premium
Company Announcements
FibroBiologics Expands At-The-Market Equity Offering Capacity
3M ago
8K
FBLG
FibroBiologics Grants Stock Options to Key Executives
PremiumCompany Announcements
FibroBiologics Grants Stock Options to Key Executives
3M ago
8K
FBLG
FibroBiologics says fibroblast spheroids drive burn healing, reduce scarring
PremiumThe Fly
FibroBiologics says fibroblast spheroids drive burn healing, reduce scarring
3M ago
FBLG
FibroBiologics releases first batch of CYWC628 for Phase 1/2 trial
PremiumThe Fly
FibroBiologics releases first batch of CYWC628 for Phase 1/2 trial
3M ago
FBLG
FibroBiologics downgraded to Hold from Buy at Maxim
PremiumThe Fly
FibroBiologics downgraded to Hold from Buy at Maxim
3M ago
FBLG
FibroBiologics Warns of ‘Going Concern’ Risk as Losses Mount and Funding Outlook Darkens
PremiumCompany AnnouncementsFibroBiologics Warns of ‘Going Concern’ Risk as Losses Mount and Funding Outlook Darkens
3M ago
FBLG
FibroBiologics Launches New At-The-Market Equity Offering
Premium
Company Announcements
FibroBiologics Launches New At-The-Market Equity Offering
3M ago
8K
FBLG
FibroBiologics reports Q1 net loss roughly ($5M)
Premium
The Fly
FibroBiologics reports Q1 net loss roughly ($5M)
3M ago
FBLG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >